Weight Loss

What Are Weight Loss? 

Obesity affects over 1 billion adults globally and is a major risk factor for type 2 diabetes, cardiovascular disease, obstructive sleep apnoea, and certain cancers. Weight loss of even 5–10% of body weight produces clinically meaningful improvements in metabolic health, blood pressure, and joint pain. Pharmacological therapy combined with lifestyle modification (diet and exercise) achieves significantly greater and more sustained weight loss than lifestyle changes alone. AmozonPill stocks 36 generic weight loss medications covering lipase inhibitors, appetite suppressants, GLP-1 receptor agonists, and combination agents — sourced from FDA-inspected, WHO-GMP manufacturers at up to 95% below brand-name prices. 

 Drug Classes Available

• Lipase Inhibitors: Orlistat 60 mg (OTC), 120 mg (prescription) — blocks pancreatic lipase in the gut, preventing absorption of approximately 30% of dietary fat. Average weight loss 3–5 kg over placebo. Requires a low-fat diet to minimise GI side effects. Brand equivalent: Xenical, Alli. 
• GLP-1 Receptor Agonists: Liraglutide 3 mg (Saxenda) — injectable GLP-1 agonist approved specifically for obesity management. Reduces appetite, slows gastric emptying. Achieves 5–8% body weight reduction over placebo. Weekly Semaglutide (Ozempic/Wegovy) is the current most effective pharmacotherapy. 
• Combination Agents: Bupropion + Naltrexone (Contrave equivalent) — Bupropion reduces appetite via dopamine/norepinephrine; Naltrexone blocks opioid reward pathways reducing food cravings. Achieves 4–5% placebo-adjusted weight loss. 
• Appetite Suppressants: Phentermine, Diethylpropion — short-term (up to 12 weeks) sympathomimetic appetite suppressants. Highly effective short-term but not approved for long-term use due to cardiovascular risks and dependence potential. 
• Antidiabetic Agents with Weight Loss Benefit: Metformin, Topiramate — not primarily weight loss agents but produce clinically meaningful weight reduction as a secondary effect. Topiramate (used primarily for epilepsy and migraine) causes significant weight loss in most patients. 

 Why Buy Generic?

• Generic Orlistat 120 mg from $22 vs $80+ for Xenical brand 

• Generic Topiramate from $14 vs $120+ for Topamax brand 

• Generic Naltrexone-Bupropion from $28 vs $250+ for Contrave brand 

• FDA-inspected, WHO-GMP-certified manufacturers 

• Free shipping on orders over $199 

How to Choose the Right Product

For overweight patients (BMI 27–30 with comorbidities) or obese patients (BMI over 30): Orlistat 120 mg with meals is the most accessible first-line pharmacotherapy — it requires a consistent low-fat diet. For patients who need appetite suppression: Bupropion-Naltrexone combination addresses food cravings as well as caloric intake. For patients with type 2 diabetes and obesity: a GLP-1 agonist (Liraglutide or Semaglutide) provides dual glycaemic and weight benefit. All pharmacotherapy should be used alongside a calorie-reduced diet, increased physical activity, and behavioural modification. 

Frequently Asked Questions

How much weight can I lose with Orlistat? 

Clinical trials show Orlistat 120 mg achieves an average of 3–5 kg more weight loss than placebo over 12 months when combined with a reduced-calorie diet. Approximately 35–45% of patients achieve more than 5% body weight loss. The weight loss is modest — Orlistat is a tool to support dietary changes, not a standalone solution.

What are Orlistat’s side effects and how do I minimise them?  

Orlistat prevents dietary fat absorption — unabsorbed fat passes to the colon, causing oily stools, flatulence, and urgent bowel movements. These side effects are directly proportional to fat intake. Following a low-fat diet (less than 30% of calories from fat, less than 15 g per meal) minimises GI side effects significantly. 

Is Semaglutide (Ozempic/Wegovy) available on AmozonPill? 

AmozonPill stocks Semaglutide injections — check the Weight Loss and Diabetes categories for current availability. Semaglutide 2.4 mg weekly (Wegovy) achieves 15–17% body weight reduction in clinical trials — the most effective pharmacological weight loss available outside bariatric surgery. 

What is the difference between Phentermine and Orlistat for weight loss? 

Phentermine is a stimulant appetite suppressant — it works immediately and powerfully but is approved only for short-term use (up to 12 weeks) and has cardiovascular risks and potential for dependence. Orlistat works peripherally in the gut, has no stimulant or cardiovascular effects, and is safe for long-term use. Orlistat is preferred for sustained weight management. 

Can weight loss medicines be used indefinitely? 

Orlistat, Liraglutide, and Bupropion-Naltrexone can be used long-term. Phentermine is restricted to 12 weeks. Semaglutide evidence supports long-term use. Weight typically returns on stopping pharmacotherapy — treatment should be viewed as a chronic management tool, not a temporary course. 

Do I need to follow a diet while on weight loss medicines? 

Yes — weight loss medicines enhance dietary adherence rather than replace it. Orlistat requires a low-fat diet. GLP-1 agonists and appetite suppressants reduce hunger but still require a calorie deficit to produce weight loss. Without dietary modification, pharmacotherapy produces minimal benefit.